Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.36 Insider Own7.19% Shs Outstand189.54M Perf Week-5.45%
Market Cap2.66B Forward P/E- EPS next Y-1.52 Insider Trans54.31% Shs Float175.59M Perf Month-15.91%
Income-321.00M PEG- EPS next Q-0.37 Inst Own91.10% Short Float19.45% Perf Quarter-2.83%
Sales-0.87M P/S- EPS this Y53.10% Inst Trans0.36% Short Ratio15.32 Perf Half Y-23.04%
Book/sh0.60 P/B23.43 EPS next Y7.30% ROA-61.00% Target Price25.73 Perf Year-31.78%
Cash/sh2.28 P/C6.16 EPS next 5Y- ROE-141.30% 52W Range11.55 - 24.99 Perf YTD-1.47%
Dividend- P/FCF- EPS past 5Y-14.80% ROI- 52W High-42.30% Beta2.06
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low24.85% ATR0.93
Employees346 Current Ratio9.90 Sales Q/Q- Oper. Margin- RSI (14)48.09 Volatility4.42% 6.34%
OptionableYes Debt/Eq0.06 EPS Q/Q39.60% Profit Margin- Rel Volume0.60 Prev Close14.06
ShortableYes LT Debt/Eq0.06 EarningsNov 06 AMC Payout- Avg Volume2.23M Price14.42
Recom2.00 SMA20-3.12% SMA50-1.07% SMA200-5.16% Volume510,423 Change2.56%
Aug-08-19Reiterated H.C. Wainwright Buy $28 → $26
Mar-27-19Initiated Berenberg Buy $40
Mar-04-19Initiated H.C. Wainwright Buy $28
Jan-18-19Downgrade Wells Fargo Outperform → Market Perform
Nov-08-18Resumed Jefferies Buy
Nov-05-18Initiated Morgan Stanley Overweight
Oct-19-18Initiated Piper Jaffray Overweight
Sep-17-18Initiated Goldman Buy $36
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Oct-13-19 04:25PM  Top Insider Buys Highlight for the Week of Oct. 11 GuruFocus.com
Oct-09-19 02:40AM  SHAREHOLDER REMINDER: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE
Oct-06-19 05:27PM  Notable Insider Buys In The Past Week: Immunomedics, Tenet Healthcare, Ulta Beauty Benzinga
Oct-05-19 08:26AM  Trade Alert: The Of Immunomedics, Inc. (NASDAQ:IMMU), Bryan Ball, Has Just Spent US$71k Buying Shares Simply Wall St.
Oct-04-19 10:00PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm GlobeNewswire
Oct-01-19 04:42PM  Immunomedics (IMMU) Reports Interim Urothelial Cancer Data Zacks
08:00AM  Immunomedics to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-30-19 04:31PM  Why This Biotech Stock Just Broke Out In Bullish Volume And Another Toppled Investor's Business Daily -7.40%
02:07PM  Seattle Genetics, Merck, Bristol-Myers Unveil Upbeat Treatment Data at Cancer Conference Barrons.com
01:13PM  Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More Benzinga
12:05PM  A Look At Benzinga Pro's Most-Searched Tickers For September 30, 2019 Benzinga
11:56AM  Call Traders Eye Biotech Stock's Big Drop Schaeffer's Investment Research
09:15AM  Seattle Genetics Climbs on Positive Trial Results for Bladder Cancer Treatment TheStreet.com
08:33AM  Immunomedics Stock Drops After Bladder-Cancer-Drug Results Disappoint TheStreet.com
Sep-28-19 12:30PM  Immunomedics Provides Corporate Update GlobeNewswire
Sep-24-19 02:55AM  SHAREHOLDER REMINDER: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE -6.62%
Sep-16-19 05:40PM  SHAREHOLDER ALERT: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE
Sep-12-19 08:35AM  Immunomedics (IMMU) Looks Good: Stock Adds 6.1% in Session Zacks
08:00AM  Immunomedics to Host Investor Event and Webcast on September 28, 2019 During ESMO Congress GlobeNewswire
Sep-06-19 09:31AM  Why Is Immunomedics (IMMU) Down 13.1% Since Last Earnings Report? Zacks
Sep-05-19 07:53PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of MGT Capital Investments, First American Financial, Immunomedics, and AAC Holdings and Encourages Investors to Contact the Firm GlobeNewswire
Sep-04-19 07:45AM  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress GlobeNewswire +6.99%
Sep-03-19 02:58PM  Shareholder Alert: Robbins Arroyo LLP Reminds Investors Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders Business Wire
Aug-28-19 08:00AM  Immunomedics to Participate in Upcoming Healthcare Conferences GlobeNewswire
Aug-08-19 06:27PM  Immunomedics, Inc. (IMMU) Q2 2019 Earnings Call Transcript Motley Fool +5.20%
04:46PM  Edited Transcript of IMMU earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
10:45AM  Immunomedics (IMMU) Posts Wider-Than-Expected Loss in Q2 Zacks
Aug-07-19 04:00PM  Immunomedics Reports Second Quarter 2019 Results and Provides Corporate Update GlobeNewswire
Aug-01-19 08:00AM  Immunomedics to Report Second Quarter 2019 Results and Host Conference Call and Webcast on August 7, 2019 GlobeNewswire
Jul-23-19 11:46AM  Drug Stock With Cheap Options Sounds Bear Signal Schaeffer's Investment Research
Jul-04-19 11:01AM  3 Hot Insider Trading Stocks To Boost Your Portfolio TipRanks
Jul-03-19 01:17PM  Are Insiders Buying Immunomedics, Inc. (NASDAQ:IMMU) Stock? Simply Wall St. +5.21%
Jun-30-19 10:09AM  Notable Insider Buys This Past Week: AbbVie, MGM and More Benzinga
Jun-09-19 04:28PM  Notable Insider Buys This Past Week: American Airlines, MGM and More Benzinga
May-29-19 08:00AM  Immunomedics to Participate in Upcoming Healthcare Conferences GlobeNewswire
May-20-19 08:41AM  2 Biotech Names See Directors Direct Cash to Their Shares TheStreet.com
May-14-19 09:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-09-19 07:40AM  Immunomedics: 1Q Earnings Snapshot Associated Press
07:00AM  Immunomedics Reports First Quarter 2019 Results and Provides Corporate Update GlobeNewswire
May-07-19 08:00AM  Immunomedics To Participate In Upcoming Healthcare Conferences GlobeNewswire
May-02-19 08:00AM  Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019 GlobeNewswire
Apr-29-19 12:46PM  Stocks making the biggest moves midday: Disney, Restaurant Brands, Gardner Denver, Target & more CNBC -5.39%
07:40AM  Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan GlobeNewswire
07:35AM  Immunomedics Announces Departure of Chief Medical Officer GlobeNewswire
Apr-26-19 01:11PM  Seattle Genetics (SGEN) Q1 Loss Narrows, Revenues Top Mark Zacks
12:07PM  Is Immunomedics, Inc. (IMMU) A Good Stock To Buy? Insider Monkey
07:17AM  Is Immunomedics, Inc. (NASDAQ:IMMU) Trading At A 34% Discount? Simply Wall St.
Apr-08-19 09:00AM  Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S. GlobeNewswire
Mar-07-19 04:01PM  Immunomedics Appoints Barbara G. Duncan to Board of Directors GlobeNewswire
Mar-04-19 08:00AM  Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-01-19 08:35AM  Research Report Identifies Axalta Coating, The Home Depot, Immunomedics, Kosmos Energy, Casa, and Ormat Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire +5.01%
07:51AM  Edited Transcript of IMMU earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 08:30AM  Lawsuit for Investors in NASDAQ: IMMU shares against Immunomedics, Inc. announced by Shareholders Foundation GlobeNewswire +6.98%
07:56AM  The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote Benzinga
07:05AM  Immunomedics Inc (IMMU) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 05:54PM  CLASS ACTION UPDATE for IMMU, ALKS and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:01PM  Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes GlobeNewswire
03:45PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
03:16PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, IMMU, PRGO and DXC GlobeNewswire
02:19PM  CLASS ACTION UPDATE for IMMU, DXC and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:44PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
12:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of IMMU, YRIV, MAXR and SVXY GlobeNewswire
10:43AM  DEADLINE ALERT - IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-24-19 10:50PM  IMMUNOMEDICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
06:06PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC Technology, Immunomedics, Natural Health, and Maiden Holdings and Encourages Investors to Contact the Firm GlobeNewswire
02:24PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU ACCESSWIRE
01:57PM  CLASS ACTION UPDATE for SOGO, IMMU, W and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:42PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
11:40AM  IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
10:55AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, IMMU, MKL and SVXY GlobeNewswire
Feb-22-19 10:50PM  Immunomedics 72 Hour Deadline Alert: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
05:27PM  CLASS ACTION UPDATE for IMMU, GSM, TYME and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:52PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
01:54PM  CLASS ACTION UPDATE for YRCW, IMMU, MKL and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:07PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Immunomedics, Inc. GlobeNewswire
12:51PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
12:35PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:13AM  CLASS ACTION UPDATE for IMMU, ALKS, UXIN and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) & DXC Technology Company (DXC) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Feb-21-19 07:00PM  CLASS ACTION UPDATE for YRCW, IMMU, W and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:57PM  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Immunomedics, Inc. (IMMU) GlobeNewswire
03:49PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
02:13PM  CLASS ACTION UPDATE for IMMU, MKL, ATVI and BRS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:48PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
11:53AM  CLASS ACTION UPDATE for IMMU, DBVT, DXC and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:47AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) & DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Feb-20-19 07:50PM  CLASS ACTION UPDATE for ARLO, SOGO, IMMU and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
05:25PM  KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for IMMUNOMEDICS, INC. Investors IMMU GlobeNewswire
05:05PM  Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine GlobeNewswire
05:00PM  IMMU UPCOMING FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Expanded Class Period IMMU GlobeNewswire
04:22PM  Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, W GlobeNewswire
04:20PM  6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU ACCESSWIRE
03:46PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
02:21PM  CLASS ACTION UPDATE for IMMU, DBVT, YRIV and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:45PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
11:54AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YRCW, IMMU, W and AVP GlobeNewswire
10:44AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
09:52AM  CLASS ACTION UPDATE for IMMU, AXGN, ATVI and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-19-19 04:10PM  IMMU: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunomedics, Inc. IMMU ACCESSWIRE
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. Its advanced antibody-drug conjugates are sacituzumab govitecan and labetuzumab govitecan, which are in advanced trials for various solid tumors and metastatic colorectal cancer, respectively. The company focuses on commercializing sacituzumab govitecan as a third-line therapy for patients with metastatic triple-negative breast cancer in the United States. The company also develops IMMU-140, a humanized antibody directed against an immune response target. Its other product candidates include products for the treatment of cancer and autoimmune diseases, including epratuzumab, an anti-CD22 antibody; veltuzumab, an anti-CD20 antibody; milatuzumab, an anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. Immunomedics, Inc. has clinical collaboration with AstraZeneca and MedImmune, to evaluate Imfinzi, a human monoclonal antibody against PD-L1, with sacituzumab govitecan as a frontline treatment of patients with TNBC and urothelial cancer; collaboration agreement with The Bayer Group for the development of epratuzumab; clinical and preclinical collaborations with academic cancer institutions, identifying new cancer indications for sacituzumab govitecan and the biology of the Trop-2 antigen; and research collaboration with the Memorial Sloan Kettering Cancer Center to investigate Sacituzumab Govitecan and Labetuzumab Govitecan in preclinical cancer models. Immunomedics, Inc. has a partnership agreement with the Samsung BioLogics Co., Ltd. to manufacture hRS7, an Immunomedics proprietary humanized antibody. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avoro Capital Advisors LLCDirectorOct 03Buy14.10500,0007,050,00022,500,000Oct 04 09:50 AM
BALL BRYANChief Quality OfficerOct 03Buy14.185,00070,89710,000Oct 03 05:30 PM
Avoro Capital Advisors LLCDirectorOct 02Buy13.231,000,00013,230,00022,000,000Oct 04 09:50 AM
Avoro Capital Advisors LLCDirectorJun 28Buy13.84250,0003,460,00021,000,000Jun 28 05:13 PM
Avoro Capital Advisors LLCDirectorJun 27Buy13.68350,0004,788,00020,750,000Jun 28 05:13 PM
Avoro Capital Advisors LLCDirectorJun 26Buy13.25400,0005,300,00020,400,000Jun 28 05:13 PM
BALL BRYANChief Quality OfficerJun 20Buy13.355,00066,7505,000Jun 21 08:47 AM
Avoro Capital Advisors LLCDirectorJun 05Buy12.47250,0003,117,50020,000,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 04Buy12.10500,0006,050,00019,750,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 03Buy12.19785,5399,575,72019,250,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorMay 15Buy14.95125,0001,868,75018,464,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 14Buy15.40125,0001,925,00018,339,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 13Buy15.07500,0007,535,00018,214,461May 15 05:25 PM